Rockville, Md.- A new rule will go into effect this fall prohibiting the extra-label use of cephalosporin antimicrobial drugs in food animals.
Rockville, Md.
- A new rule will go into effect this fall prohibiting the extra-label use of cephalosporin antimicrobial drugs in food animals.
The Food and Drug Administration gathered evidence showing that such use is likely to "contribute to the emergence of resistance and compromise human therapies," according to an FDA press release.
The ban will help protect consumers from antimicrobial-resistant strains of zoonotic foodborne bacterial pathogens and preserve the effectiveness of cephalosporin-class drugs in treating humans, the FDA says.
Comments on the rule will be accepted by the FDA until Sept. 2, but the rule will go into effect Oct. 1.
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More
Podcast CE: A Surgeon’s Perspective on Current Trends for the Management of Osteoarthritis, Part 1
May 17th 2024David L. Dycus, DVM, MS, CCRP, DACVS joins Adam Christman, DVM, MBA, to discuss a proactive approach to the diagnosis of osteoarthritis and the best tools for general practice.
Listen
dvm360 announces winners of the Veterinary Heroes program
Published: September 6th 2024 | Updated: November 5th 2024This year’s event is supported by corporate sponsor Schwarzman Animal Medical Center and category sponsors Blue Buffalo Natural, MedVet, Banfield Pet Hospital, Thrive Pet Healthcare and PRN Pharmacal.
Read More